Not suitable for individuals under 18 years of age
This can include: Frequent thoughts about specific foods, particularly those high in sugar or fat Difficulty feeling satisfied after meals, leading to continued eating Planning meals or snacks excessively throughout the day Emotional distress when food is unavailable or restricted The impact on eating behaviour can be substantial
Whilst the individual components (methionine, inositol, choline) play roles in lipid metabolism, there are no large-scale, peer-reviewed studies demonstrating that injectable formulations produce clinically meaningful weight loss or metabolic benefits
As the drug schedule changes Schedule II, Schedule III, etc., so does the abuse potential Schedule V drugs represents the least potential for abuse
GLP-1 RAs prevent the liver from putting too much sugar into your bloodstream